No Data
No Data
Hold Rating on Axsome Therapeutics Amidst Regulatory Strategy and Commercialization Prospects
Axsome Therapeutics, Inc.'s (NASDAQ:AXSM) Profit Outlook
Axsome Therapeutics, Inc. (NASDAQ:AXSM) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Axsome Therapeutics, Inc., a biopharmaceutica
Axsome Therapeutics, Inc. (NASDAQ:AXSM) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Axsome Therapeutics Is Maintained at Buy by Mizuho
Axsome Therapeutics Is Maintained at Buy by Mizuho
Axsome Therapeutics Price Target Cut to $106.00/Share From $109.00 by Mizuho
Axsome Therapeutics Price Target Cut to $106.00/Share From $109.00 by Mizuho
Express News | Mizuho Maintains Buy on Axsome Therapeutics, Lowers Price Target to $106
No Data
Salmon Klein : are you in $Macrogenics (MGNX.US)$ ? tell me when good to jump in
MangoXXXX Salmon Klein: Now
SlowndEasyTrading Salmon Klein: Do your own research , I think hovering in bottom and buy signal from pattern about to begin , do not follow me blindly my
Salmon Klein SlowndEasyTrading: I am waiting to reach 14.8 or so, but I am busy working, if it reached the bottom and you are in...any good feedback is always very welcomed bro...just that so thanks
SlowndEasyTrading Salmon Klein: Double higher bottom in intra-day might not hit below 14ish or if so still chance for 2 more trading sideways days, I am almost 25% down ( reason holding beyond top) anyway